Mercato chiuso -
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
5,04 USD | -1,18% | +11,01% | -35,30% |
Attività
Numero di dipendenti: 68
Vendite per attività
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Gene Control Medicines
100,0
%
| 15 | 100,0 % | 10 | 100,0 % | -33,23% |
Vendite per regione
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 15 | 100,0 % | 10 | 100,0 % | -33,23% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Conley Chee
CEO | Chief Executive Officer | 54 | 27/09/21 |
Nancy Simonian
CEO | Chief Executive Officer | 63 | 01/11/12 |
Jason Haas
DFI | Director of Finance/CFO | 56 | 12/10/21 |
David Roth
CTO | Chief Tech/Sci/R&D Officer | 61 | 07/12/15 |
Gerald Quirk
ADM | Chief Administrative Officer | 56 | 01/09/16 |
Karen Hunady
IRC | Investor Relations Contact | - | 01/10/22 |
Lisa Roberts
HRO | Human Resources Officer | - | 01/01/12 |
Kristin Stephens
PRN | Corporate Officer/Principal | 51 | - |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Director/Board Member | 56 | 12/06/17 | |
Tim Tyson
BRD | Director/Board Member | 71 | 16/09/22 |
Marsha Fanucci
BRD | Director/Board Member | 70 | 19/10/15 |
Deborah Dunsire
BRD | Director/Board Member | 61 | 09/09/21 |
Peter Wirth
CHM | Chairman | 73 | 30/01/17 |
Nancy Simonian
CEO | Chief Executive Officer | 63 | 01/11/12 |
Richard Young
FOU | Founder | 70 | 09/11/11 |
S. Gail Eckhardt
BRD | Director/Board Member | 66 | 08/09/20 |
Andrew Oh
BRD | Director/Board Member | 53 | 16/09/22 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 26 728 337 | 26 442 318 ( 98,93 %) | 0 | 98,93 % |
Coordinate società
Syros Pharmaceuticals, Inc.
35 CambridgePark Drive 4th floor
02140-2325, Cambridge
+617 744 1340
http://www.syros.comSettore
Revisioni EPS
Variaz. 1 gen. | Capi. | |
---|---|---|
-35,30% | 135 Mln | |
+1,51% | 42,75 Mrd | |
+49,22% | 41,61 Mrd | |
+8,57% | 41,34 Mrd | |
-12,36% | 26,59 Mrd | |
+8,92% | 25,49 Mrd | |
-25,13% | 18,12 Mrd | |
+29,17% | 12,24 Mrd | |
-3,12% | 11,76 Mrd | |
+6,35% | 11 Mrd |
- Borsa valori
- Azioni
- Azione SYRS
- Società Syros Pharmaceuticals, Inc.